Author
University of California, BerkeleyORCID 0000-0003-1991-629XUnclaimed ORCID profile · follow to get notified of new preprints
5 papers
Recent·Most cited
Henry Nelson Puerta-Guardo, Scott B. Biering, Bryan Castillo-Rojas…·Eva Harris
This study shows that flavivirus NS1 promotes virus dissemination by causing endothelial dysfunction, both in vitro and in vivo, and suggests NS1 as a therapeutic target.
Felix Pahmeier, Sabrina Hammond, Charlotte Flory…·Eva Harris
This study identifies ephrin B1 as a host factor mediating dengue virus NS1-induced endothelial barrier dysfunction and shows EFNB1-Fc fusion proteins can block this effect.
Pedro Henrique Carneiro, Erika Vanessa Jiménez-Posada, Francielle Tramontini Gomes de Sousa…·P. Robert Beatty
This study evaluates cyclodextrins' ability to reduce endothelial dysfunction and antiviral activity against DENV and SARS-CoV-2 in vitro and in vivo.
Felix Pahmeier, Stephanie R. Monticelli, Xinyi Feng…·Eva Harris
This study identifies GP38 as a viral toxin causing vascular leak and shows that specific GP38-targeting antibodies block this effect in vitro and in vivo.
Scott B. Biering, Sylvia A. Sarnik, Eleanor Wang…·Patrick D. Hsu
The paper uses CRISPR screens to identify mucins as key host factors that restrict SARS-CoV-2 infection in human lung cells.